题名 | ANGPTL2 aggravates LPS-induced septic cardiomyopathy via NLRP3-mediated inflammasome in a DUSP1-dependent pathway |
作者 | |
通讯作者 | Ke, Dong; Li, Luocheng |
发表日期 | 2023-10-01
|
DOI | |
发表期刊 | |
ISSN | 1567-5769
|
EISSN | 1878-1705
|
卷号 | 123 |
摘要 | Angiopoietin-like protein 2 (ANGPTL2) was implicated in various cardiovascular diseases; however, its role in lipopolysaccharide (LPS)-related septic cardiomyopathy remains unclear. Herein, mice were exposed to LPS to generate septic cardiomyopathy, and adeno-associated viral vector was employed to overexpress ANGPTL2 in the myocardium. Besides, mice were treated with adenoviral vector to knock down ANGPTL2 in hearts. ANGPTL2 expressions in hearts and cardiomyocytes were upregulated by LPS challenge. ANGPTL2 overexpression aggravated, while ANGPTL2 silence ameliorated LPS-associated cardiac impairment and inflammation. Mechanically, we found that ANGPTL2 activated NLRP3 inflammasome via suppressing DUSP1 signaling, and NLRP3 knockdown abrogated the detrimental role of ANGPTL2 in aggravating LPS-induced cardiac inflammation. Furthermore, DUSP1 overexpression significantly inhibited ANGPTL2-mediated NLRP3 activation, and subsequently improved LPS-related cardiac dysfunction. In summary, ANGPTL2 exacerbated septic cardiomyopathy via activating NLRP3-mediated inflammation in a DUSP1-dependent manner, and our study uncovered a promising therapeutic target in preventing septic cardiomyopathy. |
关键词 | |
相关链接 | [来源记录] |
收录类别 | |
语种 | 英语
|
学校署名 | 其他
|
WOS研究方向 | Immunology
; Pharmacology & Pharmacy
|
WOS类目 | Immunology
; Pharmacology & Pharmacy
|
WOS记录号 | WOS:001052581400001
|
出版者 | |
ESI学科分类 | PHARMACOLOGY & TOXICOLOGY
|
来源库 | Web of Science
|
引用统计 |
被引频次[WOS]:5
|
成果类型 | 期刊论文 |
条目标识符 | http://sustech.caswiz.com/handle/2SGJ60CL/553435 |
专题 | 南方科技大学第一附属医院 |
作者单位 | 1.Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430060, Hubei, Peoples R China 2.Wuhan Univ, Cardiovasc Res Inst, Wuhan 430060, Hubei, Peoples R China 3.Wuhan Univ, Renmin Hosp, Dept Gynecol, Wuhan 430060, Hubei, Peoples R China 4.Southern Univ Sci & Technol, Jinan Univ, Shenzhen Peoples Hosp, Affiliated Hosp 1,Clin Med Coll 2,Dept Cardiol,, Shenzhen 518020, Guangdong, Peoples R China 5.Shenzhen Cardiovasc Minimally Invas Med Engn Techn, Shenzhen 518020, Guangdong, Peoples R China 6.Wuhan Univ, Renmin Hosp, Dept Gastrointestinal Surg, Wuhan 430060, Hubei, Peoples R China 7.Wuhan Univ, Renmin Hosp, Dept Cardiovasc Surg, Wuhan 430060, Hubei, Peoples R China |
推荐引用方式 GB/T 7714 |
Li, Jun,Wan, Ting,Liu, Cheng,et al. ANGPTL2 aggravates LPS-induced septic cardiomyopathy via NLRP3-mediated inflammasome in a DUSP1-dependent pathway[J]. INTERNATIONAL IMMUNOPHARMACOLOGY,2023,123.
|
APA |
Li, Jun,Wan, Ting,Liu, Cheng,Liu, Huadong,Ke, Dong,&Li, Luocheng.(2023).ANGPTL2 aggravates LPS-induced septic cardiomyopathy via NLRP3-mediated inflammasome in a DUSP1-dependent pathway.INTERNATIONAL IMMUNOPHARMACOLOGY,123.
|
MLA |
Li, Jun,et al."ANGPTL2 aggravates LPS-induced septic cardiomyopathy via NLRP3-mediated inflammasome in a DUSP1-dependent pathway".INTERNATIONAL IMMUNOPHARMACOLOGY 123(2023).
|
条目包含的文件 | 条目无相关文件。 |
|
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论